6 Meridian’s Pfizer PFE Stock Holding History

6 Meridian’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$7.95M	Sell	134,673 -3,087	-2%	-$153K	0.58%	22
2021 Q3	$5.92M	Sell	137,760 -15,488	-10%	-$686K	0.47%	35
2021 Q2	$6M	Sell	153,248 -4,926	-3%	-$192K	0.48%	35
2021 Q1	$5.73M	Sell	158,174 -49,341	-24%	-$1.75M	0.49%	30
2020 Q4	$7.64M	Sell	207,515 -24,552	-11%	-$901K	0.73%	18
2020 Q3	$8.08M	Buy	+232,067	New	+$8.14M	0.84%	15
2020 Q1	–	Sell	-233,243	Closed	-$8.67M	–	537
2019 Q4	$8.67M	Buy	233,243 +531	+0.2%	+$18.9K	0.76%	39
2019 Q3	$7.93M	Sell	232,712 -79,229	-25%	-$2.88M	0.78%	38
2019 Q2	$12.8M	Buy	311,941 +329	+0.1%	+$13.1K	1.29%	20
2019 Q1	$12.6M	Sell	311,612 -107,178	-26%	-$4.29M	1.27%	22
2018 Q4	$17.3M	Sell	418,790 -8,525	-2%	-$354K	1.99%	8
2018 Q3	$17.9M	Sell	427,315 -45,986	-10%	-$1.77M	1.83%	7
2018 Q2	$16.3M	Sell	473,301 -1,146	-0.2%	-$39.2K	1.73%	10
2018 Q1	$16M	Buy	474,447 +255,314	+117%	+$8.78M	1.79%	11
2017 Q4	$7.53M	Buy	+219,133	New	+$7.47M	0.87%	34

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

6 Meridian's PFE Position: Q4 2021 in Review

6 Meridian reduced its Pfizer (PFE) stake by 2.2% in Q4 2021, selling an estimated $153K and leaving 134,673 shares worth $7.95M. The position accounts for 0.58% of the portfolio, ranked #22.

6 Meridian first reported a position in PFE in Q4 2017 and has held it in 15 quarters since. The position peaked at $17.9M in Q3 2018. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

6 Meridian held 134,673 shares of Pfizer worth $7.95M as of Q4 2021.
6 Meridian sold 3,087 Pfizer shares in Q4 2021, an estimated $153K.
Pfizer made up 0.58% of 6 Meridian's portfolio in Q4 2021, its #22 holding.
6 Meridian first reported a position in Pfizer in Q4 2017 and has held it in 15 quarters since.
6 Meridian's Pfizer position peaked at $17.9M in Q3 2018.
3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.